Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the rats.
Journal of receptor and signal transduction research（2023）
摘要
BMMSCs alleviate CKD, possibly resulting from the inhibition of kidney ferroptosis by regulating the Nrf2-Keap1/p53 pathway.
更多查看译文
关键词
Chronic kidney disease,Nrf2-keap1/p53 signaling pathway,bone marrow mesenchymal stem cells,ferroptosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要